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Glucocorticoids stimulate apoptosis in rat thymo- 
cytes that is characterized by internucleosomal DNA 
degradation. We have previously identified an 18-kDa 
calcium-dependent nuclease whose activity is associ- 
ated with  this DNA degradation. The existence of this 
nuclease has been challenged by Alnemri and Litwack 
(1989) J. Biol.  Chem. 264,  4104-4111, who suggest 
that the nuclease we observed was histone H2B. We 
report here a modified nuclease assay which uses [“PI 
DNA as a substrate that has enabled the purification 
and characterization of the 18-kDa nuclease (NUC18). 
Using Bio-Rex 70 chromatography in conjunction with 
this  assay, we show that NUC18 can be separated from 
histone H2B. Enzymatically active  NUC18, purified to 
apparent homogeneity, failed to react with  two  differ- 
ent anti-histone H2B antibodies. NUCl8 was  inactive 
in the absence of calcium and known inhibitors of 
apoptosis, i.e. zinc and aurintricarboxylic acid inhibit 
its activity. Although NUC18 activity  was detected in 
nuclear extracts of thymocytes of both control and 
glucocorticoid-treated thymocytes, these activities 
were distinct. Gel filtration analysis revealed that 
NUC18 was present as a high molecular weight com- 
plex (>lo0 kDa) in both groups of cells,  whereas it also 
existed  as a low molecular weight form in glucocorti- 
coid-treated cells. Thus, NUCl8 remains a candidate 
for the endonuclease responsible for the DNA degra- 
dation component of the apoptotic process. 
Glucocorticoids have profound effects on thymic lympho- 
cytes that ultimately lead to lymphocytolysis (2-5). Numerous 
metabolic functions of thymocytes are rapidly altered in re- 
sponse to glucocorticoid treatment.  These responses include 
altered  uptake of glucose and  other metabolic precursors (6), 
inhibition of RNA and protein synthesis (7, 8),  decreased 
ATP production (9), and  enhanced catabolism of both  protein 
and RNA (10,  11). The most profound effects, however,  seem 
to be on DNA where glucocorticoids are known to promote 
DNA degradation (2-5, 14). 
It is now  well recognized that glucocorticoid-induced lym- 
phocytolysis in the thymus  exhibits  all of the morphological 
and biochemical changes that characterize apoptosis, or pro- 
grammed cell death (2-4, 12, 13). Programmed cell death is 
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an important physiological process that occurs in  a wide range 
of biological processes including embryogenesis, differentia- 
tion, metamorphosis, and normal and neoplastic tissue growth 
(15-20). Accordingly, there are many physiological signals 
that can  stimulate apoptosis. For example, programmed cell 
death occurs in the prostate following androgen withdrawal 
(21), in cytotoxic T-lymphocytes in  the absence of interleu- 
kin-2 (22), in sympathetic  neurons deprived of nerve growth 
factor (23), in lactating mammary tissue following weaning 
due to decreased prolactin (24), and in lymphoid tissue in 
response to glucocorticoids (3, 5 ,  25). Although these and 
many other signals can initiate programmed cell death in 
various cell types, the cascade of events that subsequently 
takes place appears to be similar in most instances (15-20). 
Morphologically, cells that are committed to die undergo 
several dramatic changes (17, 18), including development of 
pyknotic nuclei, extensive chromatin condensation, and  a loss 
of cell volume. This shrinkage is associated with membrane 
convolution and  the formation of blebs on the cell surface, 
which permits the dying cells to be  recognized and removed 
by nearby phagocytic cells. Associated with chromatin  con- 
densation is the action of a nuclease activity that cleaves 
chromatin in the linker regions between nucleosomes (3, 4, 
14, 26, 27, 44). This  results  in the generation of a series of 
DNA fragments appearing in 180-200 base pair increments. 
This internucleosomal DNA degradation can be blocked  by 
inhibitors of transcription and translation (25,29,  30); hence, 
apoptotic cells appear to be responsible for their own death. 
As mentioned above, one of the hallmarks of programmed 
cell death is internucleosomal DNA degradation. This  phe- 
nomenon has been most extensively characterized in lymph- 
oid tissue following glucocorticoid treatment (3-5, 17, 28). 
Internucleosomally cleaved  DNA is detectable in the thymus 
shortly  after glucocorticoid administration (25,  28), prior to 
alterations in cell viability (3, 25, 28, 30). The killing of 
thymocytes by glucocorticoids appears to occur by a glucocor- 
ticoid receptor-dependent mechanism since this response is 
specific to glucocorticoids and since glucocorticoid antagonists 
such as RU486 prevent DNA degradation and  other  charac- 
teristics of apoptosis (25). 
We have focused our efforts on the early events that me- 
diate DNA degradation and  the role of DNA degradation in 
programmed cell death. We have previously identified a low 
molecular weight calcium-dependent nuclease(s) that may 
play a role in apoptosis (31). However, the existence of this 
nuclease has been challenged by Alnemri and Litwack (l), 
who demonstrate that histones can express artifactual nu- 
clease activity in nuclease activity gels due to  the ability of 
histones to block ethidium bromide intercalation  into DNA. 
This data, coupled with the fact that they were unable to 
18580 
This is an Open Access article under the CC BY license.
Glucocorticoid-regulated  Nuclease 18581 
purify  calcium-dependent  endonuclease  activity  in  the  CEM- 
C7 cells used for their study led Alnemri and Litwack to  
conclude that  the nuclease activity we observed in thymus 
must have  been due  to  histone  contamination. However, these 
authors have  also reported  that  the lymphoid-derived CEM- 
7 cell line that  they  studied does not  respond  to glucocorticoids 
by the same mechanism as rat thymocytes, and they have 
recently acknowledged that  the  CEM-C7 cells do  not  contain 
the calcium-dependent endonuclease (32). Hence, it is pre- 
dictable  that  Alnemri  and  Litwack were unable to  detect  the 
nuclease activity since it does not appear to be present in 
CEM-C7 cells. We report here on the use of a modified 
nuclease assay, which allows the  direct  identification of nu- 
clear extract proteins that possess nuclease activity. This 
assay does not rely on ethidium  bromide  staining;  rather, it 
employs  radiolabeled DNA  as  the  substrate.  This modification 
circumvents  the problem of detecting false  positive signals by 
ethidium bromide staining, since a loss of the radioactive 
signal is due to actual DNA loss and not due to protein 
quenching of ethidium bromide intercalation.  The  resulting 
autoradiograph confirms the presence of "holes" in  the gel 
that correspond to nuclease proteins. Using this modified 
nuclease  assay, we have localized nuclease activity  from  rat 
thymocytes  to a distinct  18-kDa  protein.  We have  proceeded 
to  purify this  protein  and  to  characterize  its  enzymatic  prop- 
erties with respect  to  pH  optimum,  divalent  cation  require- 
ments, and sensitivity to inhibitors. Furthermore we show 
that histone H2B can be effectively removed in a single 
chromatography  step,  as  confirmed by two different  antihis- 
tone H2B antisera, without causing any apparent loss in 
nuclease  activity. Finally, biochemical studies show that  al- 
though control thymocytes and glucocorticoid-treated cells 
have  equivalent  amounts of nuclease activity,  the  native size 
of the NUClB protein and/or protein complex apparently 
changes  in response to  steroid. 
MATERIALS  AND  METHODS 
Preparation of Thymocyte Nuclear Extract-Nuclear extracts were 
prepared  as described by Compton  and Cidlowski (31)  with several 
important modifications.  Briefly, male Sprague-Dawley rats (85-100 
g ) ,  obtained  from  either  Charles River Laboratories, Inc. (Wilming- 
ton,  MA)  or  Dominion  Laboratories  (Dublin, VA), were bilaterally 
adrenalectomized  and  maintained  on 0.85% NaCl and  rat chow ad 
libitum. Within 5-10 days  after  surgery,  dexamethasone  (Steraloids, 
Inc.,  Wilton,  NH), 5  mg/kg of body weight, suspended  in  phosphate- 
buffered saline  or  phosphate-buffered  saline  alone, was administered 
intraperitoneally. Thymi were harvested 5  h after injection, and 
thymocytes were prepared by  homogenization in ice-cold phosphate- 
buffered saline, followed by two Nitex mesh (202 mm) filtrations. 
Thymocytes were lysed in ice-cold hypotonic buffer (10 mM MgC1) 
containing 0.25% Nonidet  P-40. Nuclei were collected by centrifuga- 
tion  and  extracted  in 1.5 ml/thymus  in 0.4 M NaC1, 20 mM Tris-HCI, 
pH 7.5, 1 mM EDTA a t  4 "C for 1 h. Chromatin was  removed  by  a 1- 
h ultracentrifugation step a t  110,000 X g. Extracts were stored a t  
-20 "C. The dialysis step previously employed a t  this stage was 
omitted. 
SDS-PAGE'-Standard  Laemmli gels (33) were used  for  protein 
electrophoresis.  Protein  concentrations were determined by the 
method of Bradford (34),  and  protein  aliquots were heated for  10 min 
at 60 "C  in  SDS  sample buffer (10% glycerol, 2.3% SDS, 0.63 M Tris- 
HC1, pH 8.5, 5 mM dithiothreitol) immediately before loading into 
the gel. The SDS used for all gels was GIBCO-BRL  Ultrapure 
(Gaithersburg,  MD)  that was  recrystallized  twice (47).  Protein  sam- 
ples were electrophoresed using a  Hoefer Scientific Instruments  (San 
Francisco, CA) Tall  Mighty  Small  vertical  slab gel (1.5 mm X 8 cm 
X 11 cm)  consistingof a 4%  stacking gel, pH 8.5, and a 15% separating 
gel, pH 6.8. Gels were run  under  constant  current at 150-175 V for 
' The abbreviations used  are: SDS,  sodium dodecyl sulfate;  PAGE, 
polyacrylamide gel electrophoresis;  CAPS, 3-(cyclohexylam- 
ino)propanesulfonlc acid. 
1.5-2 h. Gels were stained  overnight  in 0.025% Coomassie Brilliant 
Blue R-250 and  destained for 6-8 h in 16% methanol, 5% acetic acid. 
For gels requiring silver stain  detection, Coomassie Blue-stained gels 
were further  destained  in 50% methanol  with  two washes, equilibrated 
in 20% ethanol, stained 15 min in 0.8% silver nitrate dissolved in 
0.8% NaOH, 1.5% NH,OH, rinsed  with deionized water,  and devel- 
oped in 0.01% citric acid, 0.04% formaldehyde. Reactions were 
stopped  using  destain  solution,  and  the gels were photographed. 
Protein Purification-All chromatographic  separations were per- 
formed at  4  "C, and  all  buffers  contained 20 mM Tris-HC1, pH 7.5, 1 
mM EDTA,  and  the specified concentrations of NaCl  (ranging from 
10 mM to 1.5 M). All columns were packed by  gravity flow and  then 
equilibrated  with  starting buffer at  the specified flow rate. Flow rates 
for three of the  columns  (Bio-Rex 70, DEAE-Bio-Gel,  and  phenyl- 
Sepbarose) were kept a t  approximately 40 ml/h with a Pharmacia 
LKB Biotechnology  Inc. peristaltic  pump. The flow rate for the gel 
filtration column, Bio-Gel P-100, was approximately 10 ml/h. UV 
absorbance of throughput was monitored by an Isco (Lincoln,  NE) 
model 226 absorbance monitor a t  280 nm  and recorded on an Isco 
model 615A recorder. Nuclear  extracts  (in 0.4 M NaCI) were prepared 
from 25 rat  thymi  (in  approximately 40 ml)  and passed  over  a  30-ml 
Bio-Rex 70 column  (Bio-Rad),  and  the flow through was collected. 
The flow-through  (containing  approximately 85% of the  total  protein 
in 75 ml) was  dialyzed into  10 mM NaC1, 20 mM Tris-HC1, pH 7.5, 1 
mM EDTA  and  passed over  a  20-ml DEAE-Bio-Gel A  column  (Bio- 
Rad)  and  the  flow-through was  collected. The flow-through  (250  ml, 
containing approximately 2.5% of the total extract protein) was 
adjusted to  1.5 M NaCl and chromatographed on a 20-ml phenyl- 
Sepharose  CL-4B  column  (Pharmacia/LKB). The nuclease activity 
was eluted  with 0.5 M NaC1. This  fraction  (30 ml, containing 1.9% of 
total  protein) was further  concentrated  in a  Centricell 10,000 (Poly- 
sciences, Inc., Warrington, PA) to 2 ml. The concentrated phenyl- 
Sepharose eluate was separated by preparative SDS-PAGE using 
standard Laemmli techniques. The preparative gels (Hoefer, 1.5 mm 
X 14 cm X 16-cm  vertical slab gels) were run  as described above, with 
two  modifications. The  15%  separating gels were polymerized  over- 
night, and 0.1 mM thioglycolic acid was included in the upper gel 
running buffer to  prevent  destruction of certain  amino acids  by  free 
radicals  or  oxidants  trapped  in  the g l matrix  (47). Gels were electro- 
phoresed for 4-5 h a t  150-175 V. After electrophoresis, the gel was 
soaked  in  transfer buffer (10 mM CAPS  (Sigma), pH 11, 10% meth- 
anol)  and  then  electroblotted  onto a polyvinylidene  difluoride mem- 
brane  (Immobilon P,  Millipore  Corp.,  Bedford, MA)  in  transfer buffer 
a t  0.5 A for 2.5 h a t  4 "C. Transferred  proteins were identified by 
staining with the reversible stain Ponceau S (Sigma). Gels were 
stained  in 0.5% Ponceau S in 1.0% acetic acid for 2  min and  destained 
in  water for 1 min. The protein  band a t  18 kDa was excised, and  the 
protein was eluted  using 1.0% Triton  X-100,0.5%  SDS by incubation 
for 1 h at room temperature. The  eluted  protein was stored a t  -20 "C. 
The yield of purified NUC18 protein from four such purifications 
ranged  from 2 to  5 fig. 
Nuclease Activity Assay-To identify and  characterize  the  18-kDa 
nuclease, we have used the nuclease activity gel system originally 
described by Rosentbal and Lacks (43) with several modifications. 
All activity gels were standard  Laemmli gels as described  above  using 
the Hoefer Tall Mighty Small (1.5 mm X 8 cm X 11 cm) vertical 
apparatus. 1 mg/ml heat-denatured calf thymus DNA (Sigma), along 
with 750,000 cpm of nick-translated  plasmid DNA (nick  translation 
kit from Boehringer-Mannheim), were incorporated directly into  the 
15% separating gel matrix during polymerization. Protein samples 
were heated  to 60 "C for 10 min  in  sample buffer and electrophoresed 
a t  175 V  for 1.5 h. Micrococcal nuclease (Worthington; 25,882 units/ 
mg of protein) was run as a positive control on every gel. After 
electrophoresis, the gels  were  washed overnight  in TEM buffer (50 
mM Tris-HCI, pH 7.5, 1 mM EDTA, 2 mM MgC1,) to  remove SDS, 
thereby allowing protein renaturation. Gels were stained in TEM 
buffer containing 1 pg/ml ethidium bromide (Sigma) for 30 min a t  
37 "C  and  photographed  on a 302 nm  transilluminator. To activate 
nucleases, 2 mM calcium chloride was added  to  the buffer, and  the 
gel was incubated at 37 "C for 3 h with shaking. Gel treatments 
requiring  other  cations  or  inhibitors  in  the buffer were incubated for 
1 h a t  37 "C with their respective buffers prior to the addition of 
calcium. During the 3-h incubation with calcium, the gels were 
periodically checked by UV transillumination  to localize areas  and 
extent of apparent DNA  loss. The gels were subsequently washed in 
TEM buffer containing 10% glycerol for 20 min,  dried  under vacuum 
for 2 h a t  60 "C, and processed for autoradiography overnight a t  
-70 "C. 
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Wrstrrn Blotting-Gels to he  processed for Western  analysis were 
electrophoresed as descrihed  ahove  and  then  soaked in transfer  huffer 
( I O  mM CAPS, pH 1 I ,  and IOf';, methanol)  to remove Tris and  glycine. 
Proteins were then  electrohlotted  onto  polyvinylidene  difluoride 
membranes (Immohilon 1'. Millipore Corp.) in transfer huffer at 60 
V for 3 h at 4 "C. Memhranes were not allowed to dry and were 
hlocked in Hlotto (10"; Carnation nonfat milk, 0.15 M NaCI, 10 mM 
Tris-HCI, pH 7.4, 0.05% Tween 20) for 4 h at room temperature. 
I3lots were inruhated with primary antibody overnight at 4 "C in 
lilotto, washed with I3lotto ( 3  X 5 min at room temperature) and 
hyhridized with "'"I-Protein A (ICN Riomedicals, Costa Mesa, CA) 
(5 pCi/ml Blotto) for 2 h at room temperature. Suhsequent washes 
included 2 X 5 min in Blotto and 3 X 5 min in Hlotto without 
Carnation  nonfat  milk, at room temperature.  Radiolaheled  hlots were 
dried hriefly and  exposed  to Kodak X - A H  5 film for autoradiography 
at -io "C. 
RESULTS 
Previous  studies  in  our  lahoratory  identified a group of low 
molecular  weight  proteins  (14-20  kDa)  having  apparent  nu- 
clease  activity  by  t,he  Rosenthal  and  Lacks  nuclease g l assay 
(31), that seem to he present in rat thymocyte nuclease 
extracts  only  after  glucocorticoid  treatment.  Our  attempts to 
purify  this  nuclease(s)  were  confounded  by  the  copurification 
of histone H2R, as confirmed by protein microsequencing. 
The  presence of histone H,R in  this  molecular  weight  range 
of  lymphoid  cell  nuclear  extracts  was  independently  reported 
by Alnemri and Litwack (1). This data, combined with the 
observation  that  histone  can  hlock  ethidium  hromide  binding 
to   DNA (1, 35),  which  was  the  nuclease  detection  method  on 
which we had previously relied, led several investigators to 
conclude  that  the  nuclease(s)  did  not  exist (1, 36, 46).  Fig. 1 
analyzes the nuclease activity exhibited by micrococcal nu- 
clease, histone HIR, and 0.4 M control  and  dexamethasone- 
treated thymocyte nuclear extracts using the modified nu- 
clease  assay  with  "'P-radioactive  DNA  suhstrate.  Micrococcal 
nuclease and both t.he control and dexamethasone extracts 
caused  the  generation of round clearings of the  radioactive 
DNA,  whereas  the  histone H,R protein  was  unable to clear 
t h e  gel of radioactive DNA. However, in contrast to our 
previous  studies (3), as shown  in Fig. 1, there is no  difference 
in  the  amount of nuclease  activity  in  the  control  and  dexa- 
methasone  extracts.  The  difference  between  the  present  find- 
ings and our previous ohservations prohahly reflect several 
factors.  First,  extraction  conditions  used  previously  did  clearly 
extract more histone prot,eins from dexamethasone-treated 
thymocytes  (data  not  shown).  Thus,  we  believe  that  the 
differences we ohserved  previously  reflected  the  assay  which 
detected  both  histone  and  nuclease  activity.  Second,  the  mod- 
ified  assay  now  utilized  is  more  sensitive  and  measures  only 
nuclease  activity.  Thus it seems  likely  that  our  previous  assay 
was  not  sufficiently  sensitive  to  detect  nuclease  activity  with 
-MN- -H2B- DEX CON 
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FIG. 1 .  Nuclease  activity  assay  comparing  nuclease  activity 
with  histone H2B. The modifirtl nurlense assay as descrihed  under 
"Materials and Methods" WRS used to analyze nuclease activity in 
three dil'ferent protein  preparations.  Microcorcal  nuclease ( M N )  
lanes A.  H ,  and  ('contain 0.1,0.5, and  1.0 pg of  micrococcal  nuclease; 
H.R lanes A ,  I3  and ('contain 0.1, 0.5,  and 1.0 pg of  histone  HZB;  and 
control ( c o n )  and  dexamethasone (&x) lanes  contain 2.5 pgof protein 
extracts. 
the   amounts  of nuclear  extract  loaded  on  the gels. Finally, as 
shown  in  the  HIR  panel of Fig. 1, some  partial  clearing  around 
the  histone  protein is occasionally  ohserved,  whereas  the 
center of the  protein  spot  actually  gets  darker.  This  effect is 
independent of calcium  and is prohahly  caused  by  the  ahility 
of histones to hind  and  concentrate a small  amount of DNA 
within  their  vicinity.  Alternatively,  this  partial  clearing  may 
reflect some contamination of t.he histone H?R preparation 
with a nuclease similar to NUC18. The fact that extensive 
boiling  in SDS  can  aholish  the  partial  clearing  due  to  histone 
(data  not  shown)  supports  the  lat.ter  explanation  and  suggests 
that   the  nuclease is distinct  from H,R. Rased  on  these data, 
we  concluded  that  the  nuclease  does  exist  and  sought a 
technique  that  would  separat,e  the  nuclease  from  histone H,R.
As a first  approach  toward  purifying  the  nuclease,  the  NaCI 
concentration of the  extraction  huffer  was  lowered  from 0 5  
M to 0.4 M in  order to extract  less  histone  proteins,  and  Rio- 
Rex  70  chromatography  was  suhsequently  used  under  condi- 
tions in which histones are known to have high affinity for 
the  column  matrix (38). Rio-Rex 70 chromatography in the 
presence of 0.4 M NaCl was  sufficient to remove all detectahle 
histone  H?R  without  appreciahle oss of nuclease  activity  (Fig. 
2). T h e  removal of histone H,R was confirmed hv Western 
hlot  analysis.  The f a r  left panel shows a Coomassie  stain of 
equal  amounts of protein  from  crude  extract  (the 0.4 M NaCl 
dexamethasone  extracts)  and  Rio-Rex 70 steps  (dexametha- 
sone extract after passage over Rio-Rex 70 in 0.4 M NaCI). 
This  column  separation  resulted  in  the loss of approximately 
15% of the  total  extract  proteins.  However,  nuclease  activity 
of the  18-kDa  protein is not  depleted, as shown  in  the rniddlr 
panel, where crude extract and Rio-Rex 70 fractions have 
similar nuclease activit.ies. Western hlot analysis, shown in 
the  far right panel of  Fig. 2, confirms  that,  although  histone 
H,R is present  in  dexamethasone  extracts,  it is undetectahle 
following Rio-Rex 70 chromatography. These data demon- 
strate  that  Rio-Rex  70  treatment  effectively  removes all de- 
tectable  histone H,R from  dexamethasone  extracts  while  re- 
taining  the  nuclease  activity  associated  with  the  18-kDa pro- 
tein. 
Having  efficiently  separated NUC18 from  histone  H,R,  two 
additional chromatographic steps were used to purify this 
nuclease. We employed an anion exchange column, DEAE- 
Rio-Gel A, to which a majority of the  nuclease  did  not  hind 
Protein Nuclease Western 
Stam Actwly Analysls 
FIG. 2. Rio-Rex 70 removes histone H2R. 1nrtr.s 1 and 2 in 
each pnnrl rontain equal amounts of t hr 0 . 4  SaCl tlexnmethnsone 
extract (Crudc I:'xtroct) and  the 0.4 M Nac'l liio-Rex 70 fraction. The 
k / t  pond depicts a Coornassie lirilliant Iilrlr-stained gel containing 
1 0  pg of earh  extract,  the rniddlr,poncl represents  an arltoradiographir 
film of the modified nuclease assav o f  5 pg of earh protein rxtr:lrt, 
and  the right pnncl shows a Western hlnt o f  'LO pg of earh  cxtrart v r  
2 pg of H:,N hvhridized  with  anti-histone H .Ii antihotly  (generously 
hlot supplied hv Dr. Chi-fiom  Chae,  I'nivrrsity  of  Sorth  ('arnlina). 
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in  the presence of 10 mM NaC1. Under  these  conditions, 82.5% 
of the  total  extract  proteins  bound  to  this  column, leaving 
only 2.5% after  the  first two columns  (15% was  removed by 
the Bio-Rex 70 column,  and 82.5% was removed by DEAE 
chromatography).  The  remaining  protein was bound  to  the 
hydrophobic interaction column, phenyl-Sepharose, in the 
presence of 1.5 M NaC1, and  NUCl8 nuclease activity was 
eluted with 0.5 M NaCl. This  step allowed concentration of 
the sample from  over 250 ml down to 20 ml  while  removing 
an  additional 0.5% of the  total  protein. Fig. 3 shows a silver- 
stained gel of samples  obtained from this  purification scheme. 
The  first four lanes  contain  equal  quantities of the  protein 
from  each purification step. Following Bio-Rex 70 chromatog- 
raphy, loss of the negatively staining low molecular weight 
histones is apparent, and in the phenyl-Sepharose lane, a 
protein of 18 kDa has been enriched.  The  phenyl-Sepharose 
fraction was further  concentrated  and subjected to preparative 
SDS-PAGE  and  electroblotting as described under  “Materials 
and Methods.” The  eluted  NUCl8  protein  is  shown  in  the 
SDS-PAGE  lane of Fig. 3. The  protein  appears homogeneous 
by this criterion; however, it is impossible to preclude co- 
migration with other  proteins by this technique. 
Following purification by this  scheme,  NUCl8  protein  re- 
tains biological activity, as  shown  in Fig. 4. The  second  lane 
in Fig. 4 is an autoradiographic exposure of the nuclease 
activity gel assay demonstrating  the  calcium-dependent  nu- 
clease  activity of purified NUC18. The  amount of protein  in 
the nuclease activity  lane  represents  approximately  one-fifth 
the  amount of protein shown silver-stained  in  the  first  lane 
of Fig. 4. The  last two lanes  in Fig. 4  show a Western  analysis 
of equal quantities of NUCl8  and  histone  H2B hybridized 
with a  second anti-histone  H2B  antiserum.  The  NUC18  lane 
contains no detectable histone H2B, whereas the H2B lane 
strongly  reacts  with  the  antiserum.  Thus, we have purified a 
biologically active NUC18 protein that is immunologically 
distinct from histone H2B. 
We next  sought  to  characterize  the  enzymatic  requirements 
of this  protein  and  to  compare  them  with  other known nu- 
cleases. We  used the nuclease activity gel system  to  charac- 
terize the pH and ionic requirements of NUC18. NUCl8 
requires a neutral  pH,  having  optimal  activity a t   pH 7.0-8.5 
(data not shown). Fig. 5 shows results from representative 
gels of several  more of these  experiments.  Each  panel  contains 
three  lanes  that  correspond  to micrococcal nuclease (0.2 pg) 
15.4 - 
FIG. 3. SDS-PAGE analysis  of  NUC18 purification. Aliquots 
(10 pg) of fractions  after  each purification step were electrophoresed 
in  15% SDS-polyacrylamide gels and  subsequently  silver-stained  as 
described under  “Materials  and Methods.” Lane 1,0.4 M NaCl  dexa- 
methasone  extract; lane 2, 0.4 M NaCl  Bio-Rex 70 eluant; lane 3, 10 
mM NaCl DEAE  eluant; lane 4, 0.5 M NaCl  phenyl-Sepharose  frac- 
tion; lane 5, approximately 1.5 pg of NUC18  after  transfer  and  elution 
following SDS-PAGE. 
Silver  Nuclease 
Stain  Activity  Western Blot 
FIG. 4. Nuclease activity and Western  blot  of purified 
NUC18. Using the modified nuclease activity assay described in 
detail  under  “Materials  and  Methods,” nuclease  activity appears  as a 
white hole on a dark radiolabeled  DNA  background. NUCl8 purified 
as described in  the  text  results  in enzymatically active nuclease as 
shown here. On the left is a silver stain of approximately 1.5 pg 
NUC18, and on the right is a nuclease gel assay of approximately 0.3 
pg of NUC18 protein. Western analysis was performed using an 
antibody to histone H2B (graciously supplied by Michael Bustin, 
National Cancer Institute, NIH) and developed with ”‘I-labeled 
protein A as described under  “Materials  and Methods.” The /eft lane 
contains  approximately 2 pg of purified NUC18, and  the right lane 
contains 2 pg of purified histone H?B. 
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FIG. 5. Characterization of purified nuclease activity. Pu- 
rified nucleases were analyzed by the modified nuclease gel assay 
described under  “Materials  and  Methods.” Following electrophoresis, 
gels were washed overnight to remove SDS  and  then soaked in TEM 
Buffer containing either 2 mM MgCI,, MnC12 or ZnCI?, or 1 mM 
aurintricarboxylic  acid for 1 h prior  to  the  addition of calcium. Gels 
were then  incubated  in  the presence of 2 mM CaCI? for 3 h a t  37 “C. 
Lane I in each panel contains 0.25 pg of micrococcal nuclease ( M N ) ,  
lane 2 contains 0.20 pg of pancreatic DNAse I, and lane 3 contains 
approximately 0.20 pg of NUC18. The first  panel depicts a gel in the 
absence of calcium, and  the next panel shows  nuclease  activity in  the 
presence of 2 mM calcium, demonstrating  that all three enzymes are 
in  fact  calcium-dependent. Panel 3,  the gel was incubated in TEM 
buffer plus 2 mM zinc plus calcium; panel 4, TEM buffer plus  1 mM 
aurintricarboxylic acid plus calcium; in panel 5 ,  T E  buffer (TEM 
without  the MgCIJ plus 2 mM MnCI? in  the absence of calcium. 
and  mammalian  DNase I (1 pg) as  the two  positive  nuclease 
controls  and  NUCl8 (0.2 pg of purified NUC18). The first 
panel demonstrates  that,  in  the absence of calcium, all three 
enzymes are inactive. The second panel shows that,  in  the 
presence of 2 mM calcium, all three enzymes, micrococcal 
nuclease, DNase I, and NUC18, are  activated.  The third panel 
demonstrates  that a 1-h  pretreatment with  2 mM zinc before 
addition of 2 mM CaC12 was sufficient to inhibit nuclease 
activity of NUC18. This  concurs  with a report of Cohen and 
Duke  (28)  in which internucleosomal DNA cleavage could be 
prevented by treatment with zinc. In  the fourth panel, a 1-h 
pretreatment  with 1 mM aurintricarboxylic acid prevents cal- 
cium-dependent  activity of NUC18, and micrococcal nuclease 
(MN) .  Aurintricarboxylic  acid is a nonspecific nuclease inhib- 
itor (45) and has been reported to block internucleosomal 
DNA cleavage and  other  properties of apoptosis in thymocytes 
(41). The last panel demonstrates  that, in the presence of 2 
mM manganese and no calcium, both micrococcal nuclease 
and  DNase I are  activated while NUC18 remains  unactivated. 
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This result suggests that  NUC18  is probably not  related  to 
mammalian  DNase  that  can be activated by manganese. 
Having proven the  existence of an  18-kDa nuclease with 
unique  enzymatic  requirements, we next wished to re-examine 
the regulation of the  NUCl8  protein by glucocorticoids since 
studies from other  laboratories (14, 24), as well as  our own 
data  presented  in Fig. 1 suggested that  it  is  also  present  in 
control cells. We evaluated  the  presence of NUC18 in control 
and dexamethasone extracts further by using gel filtration 
chromatography, which allows the  determination of the mo- 
lecular weight of the NUC18 protein under nondenaturing 
conditions.  SDS-PAGE nuclease activity gel analysis of the 
column  fractions is depicted in Fig. 6. The far right lane in 
the upper and lower panels demonstrates similar nuclease 
activity in extracts obtained from control and dexametha- 
sone-treated cells. Clearing of radioactive DNA  through  the 
upper  portion of the  lanes may reflect trace  deposits of the 
enzyme  during electrophoresis, since more protein was  loaded 
in  these  samples  than  in previous figures. The lower panel 
demonstrates  that  NUCl8  from  dexamethasone  extracts 
elutes a t  two different molecular  weights during gel filtration; 
one peak elutes at  approximately 25 kDa and  the  other  peak 
elutes  in  the void volume (VV),  having a molecular mass of 
greater  than 100 kDa. Interestingly, NUC18, as detected by 
SDS nuclease activity gels, is present only in  the void volume 
after gel filtration of the  control  extracts  (the 25-kDa form  is 
absent under the nondenaturing gel filtration conditions). 
These  data suggest that  NUC18  can  exist  in two  forms; one 
is  perhaps  bound  to  other  proteins  or  to  DNA  and  exists as a 
high  molecular weight complex, and  the second form  exists a t  
a molecular  weight very close to  its  apparent molecular  weight 
by SDS-PAGE.  Since  control  extracts  contain  only  the high 
molecular weight form, we conclude that dexamethasone 
treatment  stimulates  either  synthesis of NUC18  or release of 
the smaller  molecular  weight  form from  the high  molecular 
weight complex. The  latter  mechanism would explain how the 
nuclease  in the  untreated  thymocytes could be present  without 
generating measurable  DNA degradation,  whereas  the  dexa- 
methasone-treated  thymocyte extensively  degrades its DNA. 
t t 
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FIG. 6. Bio-Gel P-100 elution  profile  of  control  and  dexa- 
methasone  extract. 5 mg each of control (con)  (upper  panel) and 
dexamethasone ( & x )  (lower panel) 0.4 M NaCl extracts were frac- 
tionated on a  75-ml  Bio-Gel P-100 column in the presence of 0.4 M 
NaCI, 20 mM Tris, pH 7.8, and 1 mM EDTA. 1.5-ml fractions were 
collected, and a 20-pl aliquot from each fraction was analyzed by the 
modified nuclease assay. Molecular weight markers are as follows: 
blue dextran for the void volume ( V V ) ;  ovalbumin (OV) ,  43,000; 
chymotrypsinogen ( C H Y ) ,  25,000. Lane 1 in each panel contains 0.25 
pg of micrococcal nuclease ( M N ) ,  and the last lune (7') in each panel 
contains  5 pg total extract (7') of either control or dexamethasone 
0.4 M NaCl extract. Lanes 2-20 contain sequential 20-pl aliquots of 
column fractions from the  Bio-Gel P-100 column. 
These  mechanisms would also be consistent with the  litera- 
ture  and  our previous data  demonstrating  that inhibition of 
protein  synthesis blocks  glucocorticoid-induced  lymphocyto- 
lysis and suggest that  synthesis of some protein,  perhaps  an 
activator  protein  or  the nuclease  itself, is required for DNA 
degradation  to occur (25, 29, 30). 
DISCUSSION 
We  have  purified an  18-kDa nuclease (NUC18) from dex- 
amethasone-treated  rat  thymocytes  using  the combined ap- 
proaches of ion exchange chromatography, hydrophobic in- 
teraction  chromatography,  and  preparative  SDS-PAGE. 
NUCl8  has  calcium-dependent nuclease activity by the  nu- 
clease activity gel assay. Our previous purification strategy 
resulted in a preparation of NUCl8  that was contaminated 
with histone  H2B,  as confirmed by protein microsequencing. 
However, as  demonstrated by Western  blot analysis, this new 
purification scheme  results  in purified NUC18  that is distinct 
from histone H2B. These  findings  refute  three  recent  reports 
(1, 36, 46) that suggest that the 15-20 kDa endonuclease 
activity  in lymphoid  cells is  due  to  histone  H2B.  These  authors 
concluded that  the "nuclease  activity" we reported was due to 
the  ability of histones  to  quench  the fluorescence of ethidium 
bromide-stained DNA. However, Rosenthal  and  Lacks  (35), 
who initially developed this nuclease assay,  subsequently dem- 
onstrated  that, if radioactive DNA is  incorporated  into  the 
gel, only  nuclease activity will be detected,  since  histones  do 
not block the radioactive emissions from *lP. Further,  they 
(35) crucially demonstrated that detection of histones by 
ethidium bromide staining  takes place  in the  absence of added 
divalent  cations  and,  in  fact, may be inhibited by the presence 
of cations. The  data  presented  in  this  manuscript  are  consist- 
ent  with  these  criteria for discerning nuclease  activity from 
DNA-binding  activity, since  NUC18  is  calcium-dependent in 
these  activity gels. We believe that  the discrepancy  between 
our  studies  and Alnemri and Litwack  involving  CEM-C7 cells 
reflect their use of inappropriate cells as a  source of nuclei for 
nuclease  purification. I t  is well recognized that  CEM-C7 cells 
do  not respond to glucocorticoids by the  same  mechanisms  as 
do  rat  thymocytes  and,  therefore,  it is likely that  these cells 
may not  express  the  appropriate nuclease. In fact, following 
their  initial  report, Alnemri and Litwack  have  subsequently 
published that  CEM-C7 cells do  not  contain a calcium-de- 
pendent endonuclease  (32). This  observation readily explains 
why these investigators were unable to purify calcium-de- 
pendent nuclease activity from nuclear  extracts of CEM-C7 
cells. 
In the present study, we have used a modified nuclease 
activity gel system  to  characterize  the nuclease  activity of the 
purified NUCl8  protein.  The nuclease  requires  a neutral  pH 
and  is  calcium-dependent.  NUCl8  is a  basic protein, having 
a PI of 8.5 or  greater  as  determined by chromatofocusing (data 
not  shown).  In  addition, NUC18 is probably not related to 
DNase I since DNase I but not NUCl8 is stimulated by 
manganese alone. Many  reports  in  the  literature refer to a 
calcium- and  magnesium-dependent endonuclease (14,28,37, 
38) in  thymocytes; however, the  requirement of NUC18 for 
magnesium can  not be rigorously tested in our  studies because 
high concentrations of magnesium are present during the 
extraction procedure. NUC18  is  inhibited by both zinc and a 
general nuclease inhibitor,  aurintricarboxylic acid. Zinc treat- 
ment of thymocytes in uitro has been shown to prevent 
internucleosomal DNA degradation,  as well as thymocyte cell 
death (28). In  addition, zinc-deficient mice have  smaller than 
normal  thymi, whereas the  thymus  remains  normal in size if 
the zinc-deficient mice have  been previously adrenalectomized 
Glucocorticoid-rc 
(39,40). These  results suggest that zinc  may exert  a protective 
effect against glucocorticoid-induced lymphocytolysis in  the 
thymus. Aurintricarboxylic acid has also been shown to block 
internucleosomal DNA  cleavage and apoptosis (41). The  en- 
zymatic characteristics of NUC18, as well as  its sensitivity to 
specific inhibitors known to block internucleosomal DNA 
cleavage in lymphoid cells, strongly support the hypothesis 
that  NUCl8 plays an important role in glucocorticoid-induced 
DNA degradation integral to  the apoptotic process. 
NUC18  is present in extracts from both control and  dexa- 
methasone-treated thymocytes in a high molecular weight 
complex (>IO0 kDa),  as determined by  gel filtration analysis. 
However, dexamethasone extracts differ from controls  in that 
they also contain NUCl8  in fractions that correspond to a 
molecular weight of approximately 25 kDa. There  are several 
possible explanations for the occurrence of this 25 kDa nu- 
clease activity in  dexamethasone-treated thymocytes and  its 
absence in control extracts.  These possibilities include differ- 
ential  extraction of proteins in the two extracts due to  the 
presence of degraded DNA in  the dexamethasone extracts; 
induction of enzyme activity through  transcriptional  activa- 
tion via the classical steroid receptor pathway; specific nu- 
clease mRNA stabilization; and activation via nongenomic 
mechanisms, perhaps due to availability of cofactors or to 
conversion from an inactive precursor into an active nuclease. 
We do not believe that differential extraction explains our 
data since the 25-kDa form is apparently  not associated with 
DNA, as  it does not  bind to DEAE-Bio-Gel A, whereas the 
high molecular  weight form does bind to  the DEAE column 
and exactly coelutes with the DNA (data  not shown). Tran- 
scriptional activation remains a possible mechanism, since 
genetic evidence exists that indicates that cell death in re- 
sponse to steroid hormone is mediated by a specific gene 
product or “lysis” gene (42). The exact role for this lysis gene 
is unclear at  this time. Its product may be responsible for 
causing an influx of calcium that is required since the enzyme 
is calcium-dependent, it may induce another  protein respon- 
sible for initiating  a cascade of events that lead to activation 
of internucleosomal cleavage activity, or it may actually be 
involved in the internucleosomal cleavage itself. 
Based on the ubiquitous observation that internucleosomal 
DNA degradation of DNA occurs in all reported instances of 
apoptosis, we hypothesize that  this DNA degradation is the 
first irreversible process in programmed cell death. The cor- 
relation between detection of this low molecular weight nu- 
clease and DNA degradation makes this protein a strong 
candidate for the apoptotic nuclease. 
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